CD164
CD164 (CD164 molecule, also known as MUC-24 or MGC-24) is a transmembrane sialomucin and cell adhesion molecule. It regulates the adhesion, proliferation and migration of haematopoietic progenitor cells and has roles in myogenesis. Browse Assay Genie's current range of CD164 research reagents below, or read on for the biology behind the target.
CD164 is a sialomucin that may play a key role in haematopoiesis. It is thought to facilitate the adhesion of CD34(+) cells to the stroma and to negatively regulate the proliferation of CD34(+)CD38(lo/-) cells. It also modulates the migration of umbilical cord blood CD133+ cells, an effect mediated through the CXCL12/CXCR4 axis. The encoded protein interacts with the C-X-C chemokine receptor type 4 (CXCR4).
Outside the haematopoietic compartment, CD164 promotes myogenesis by enhancing CXCR4-dependent cell motility. It positively regulates myoblast migration and promotes the fusion of myoblasts into myotubes, so it may regulate muscle development. It may also play an important role in prostate cancer metastasis and in the infiltration of bone marrow by cancer cells.
The CD164 gene encodes a transmembrane protein that belongs to the CD164 family and is listed in the HGNC group of CD molecules. UniProt records it in the lysosome membrane, endosome membrane and cell membrane, and as a secreted form. The protein is also called sialomucin core protein 24, and earlier gene names were CD164 antigen, sialomucin. Elevated CD164 expression has been observed in patients with Sezary syndrome, a type of blood cancer, and a mutation in the gene may be associated with impaired hearing (the DFNA66 designation). Mouse and rat both carry a Cd164 ortholog.
CD164 may facilitate adhesion of CD34(+) cells to the stroma and negatively regulate CD34(+)CD38(lo/-) proliferation, making it relevant to progenitor cell biology.
CD164 modulates migration of cord blood CD133+ cells through the CXCL12/CXCR4 axis and interacts with CXCR4.
CD164 enhances CXCR4-dependent motility, promoting myoblast migration and fusion into myotubes.
CD164 may contribute to prostate cancer metastasis and bone marrow infiltration, and its expression is elevated in Sezary syndrome.
CD164 is a transmembrane sialomucin and adhesion molecule. It regulates the adhesion, proliferation and migration of haematopoietic progenitor cells, interacts with CXCR4, and promotes myoblast migration and fusion into myotubes. It may also contribute to prostate cancer metastasis to bone marrow.
CD164 is also called sialomucin core protein 24, MUC-24, MGC-24, MGC-24v and DFNA66. Earlier HGNC names were CD164 antigen, sialomucin and CD164 molecule, sialomucin. The current approved name is CD164 molecule, and the protein belongs to the CD164 family.
Mouse and rat both have a Cd164 ortholog, so the gene is conserved across these species. Check the datasheet of any product for its validated reactivity. Elevated expression is reported in Sezary syndrome, and a mutation may be associated with impaired hearing.
Other CD molecules, adhesion proteins and progenitor cell markers with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q04900; product specifications from Assay Genie datasheets.